Graftless sinus augmentation with simultaneous dental implant placement: clinical results and biological perspectives. Issue 9 (September 2016)

• Record Type: Journal Article
• Authors: Falah, M.; Sohn, D.-S.; Srouji, S.
• Is Part Of: International journal of oral & maxillofacial surgery. Volume 45:Issue 9(2016:Sep.)
• Page Start: 1147
• Page End: 1153
• Publication Date: 2016-09
• Subjects: sinus lifting -- maxillary sinus -- Schneiderian membrane -- fibrin clot; Mouth -- Surgery -- Periodicals; Maxilla -- Surgery -- Periodicals; Dentistry -- Periodicals; Dentistry, Operative; Oral Surgical Procedures; Surgery, Oral; Dentistry; Maxilla -- Surgery; Mouth -- Surgery; Electronic journals; Periodicals; 617.52059
• DOI: 10.1016/j.ijom.2016.05.006
• Languages: English
• ISSNs: 0901-5027

Abstract

Abstract: After a sinus lifting procedure, the compartment around the implants under the sinus mucosal lining in the sinus floor is filled with a blood clot from surrounding bleeding. The aim of this study was to evaluate the feasibility of bone formation following graftless sinus lifting with the simultaneous placement of dental implants. Thirty graftless sinus lifting procedures were performed and 72 dental implants placed in 18 consecutive patients, using the lateral window approach. Clinical and radiological follow-up was conducted throughout the 6-month healing period. Biopsies of 30 cases were collected at 6 months post-treatment: 15 biopsies were taken from the newly formed bone near the basal floor and 15 from the newly formed bone near the elevated membrane. New bone consolidation in the maxillary sinus was apparent radiologically and histologically at 6 months after sinus augmentation, providing an average 6.14 ± 1.34 mm of bone-gain. Based on histological analysis and histomorphometric data, the consolidated bone in the augmented sinus comprised 56.7 ± 11.9% to 59.9 ± 13.4% vital bone tissue. Out of the 72 implants placed, only four failed, indicating a 94% overall implant survival rate. Based on this case series, blood clot can be considered autologous osteogenic graft material, to which osteoprogenitors can migrate, differentiate, and regenerate bone.